Melbourne, Australia; 3 April 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce that, further to the announcement on 3 March 2023, Mr Justin Cahill commences in the role of Chief Financial Officer (CFO) and Company Secretary today. Mr Cahill has extensive corporate finance and leadership experience in the biopharmaceutical, food, and agricultural sectors for private and ASX-listed companies including CSL. To facilitate a smooth transition of company secretarial responsibilities Ms Tracy Weimar will continue as Joint Company Secretary for a handover period. For the purposes of ASX Listing Rule 12.6, both Mr Cahill and Ms Weimar are persons responsible for communications between the Company and ASX.

View the full announcement here.